These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9823572)

  • 41. [Chronic hepatitis C and B. What can be accomplished with antiviral therapy].
    MMW Fortschr Med; 2007 Feb; 149(7):14. PubMed ID: 17615650
    [No Abstract]   [Full Text] [Related]  

  • 42. Chronic viral hepatitis, the treatment with spiruline for one month has no effect on the aminotransferases.
    Băicuş C; Tănăsescu C
    Rom J Intern Med; 2002; 40(1-4):89-94. PubMed ID: 15526544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis C virus carriers with persistently normal aminotransferase levels: healthy people or true patients?
    Puoti C; Castellacci R; Montagnese F
    Dig Liver Dis; 2000 Oct; 32(7):634-43. PubMed ID: 11142566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Host factors determining the outcome of IFN treatment for chronic hepatitis C].
    Kiyosawa K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):481-4. PubMed ID: 15359845
    [No Abstract]   [Full Text] [Related]  

  • 45. Iron and chronic viral hepatitis.
    Bonkovsky HL; Banner BF; Rothman AL
    Hepatology; 1997 Mar; 25(3):759-68. PubMed ID: 9049232
    [No Abstract]   [Full Text] [Related]  

  • 46. Interferon-based hepatitis C antiviral treatment outcomes may be predicted by alanine aminotransferase levels.
    Kelly E; Blach S; Razavi H; Cooper C
    Can J Gastroenterol Hepatol; 2015; 29(8):407-8. PubMed ID: 26301333
    [No Abstract]   [Full Text] [Related]  

  • 47. A new era of interferon treatment for chronic hepatitis C is coming.
    Kiyosawa K; Tanaka E
    J Gastroenterol; 2000; 35(8):652-4. PubMed ID: 10955608
    [No Abstract]   [Full Text] [Related]  

  • 48. [Interferon free recovery for almost all patients].
    Einecke D
    MMW Fortschr Med; 2015 Mar; 157(4):71. PubMed ID: 25743991
    [No Abstract]   [Full Text] [Related]  

  • 49. Antipyrine clearance and response to interferon therapy in chronic hepatitis.
    Fabbri A; Bianchi GP; Marchesini G
    Hepatology; 1997 Feb; 25(2):500-2. PubMed ID: 9021973
    [No Abstract]   [Full Text] [Related]  

  • 50. [Parenteral acute viral hepatitis: current diagnosis, prevention and treatment].
    Podymova SD
    Eksp Klin Gastroenterol; 2012; (6):76-85. PubMed ID: 23402196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum cholesterol and low-density lipoprotein cholesterol levels as predictors of response to interferon therapy for chronic hepatitis C.
    Minuk GY; Weinstein S; Kaita KD
    Ann Intern Med; 2000 May; 132(9):761-2. PubMed ID: 10787379
    [No Abstract]   [Full Text] [Related]  

  • 52. Antiviral treatment for hepatitis C cirrhosis: is the effort justified?
    Black M; Thomas R
    Ann Intern Med; 2008 Sep; 149(6):427-8. PubMed ID: 18794563
    [No Abstract]   [Full Text] [Related]  

  • 53. Hepatitis C infection with normal liver chemistry tests.
    Fried MW
    Clin Gastroenterol Hepatol; 2008 May; 6(5):503-5. PubMed ID: 18407797
    [No Abstract]   [Full Text] [Related]  

  • 54. [Interferons].
    Pape GR
    Schweiz Rundsch Med Prax; 1992 Sep; 81(36):1039-40. PubMed ID: 1384099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Higher dose of interferon treatment of chronic hepatitis C patient with primary non-response: a case report].
    Liu YL; Chen XY
    Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):950. PubMed ID: 21205489
    [No Abstract]   [Full Text] [Related]  

  • 56. [Splenectomy before antiviral therapy for patients with chronic hepatitis C with thrombocytopenia].
    Aizawa N; Nishiguchi S
    Nihon Rinsho; 2011 May; 69 Suppl 4():201-5. PubMed ID: 22096919
    [No Abstract]   [Full Text] [Related]  

  • 57. Interferon education: the need.
    Dallinger M
    Aust Nurs J; 1998 Mar; 5(8):20-2. PubMed ID: 9592407
    [No Abstract]   [Full Text] [Related]  

  • 58. [Recurrence of hepatitis A].
    Saibara T; Onishi S
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():474-7. PubMed ID: 15453368
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy of interferon therapy for patients who develop chronic hepatitis C after an acute course of hepatitis.
    Okuno T; Arai K; Shindo M
    J Hepatol; 1997 Oct; 27(4):767-8. PubMed ID: 9365056
    [No Abstract]   [Full Text] [Related]  

  • 60. Activation of the endogenous interferon system, expression of interferon-alpha receptors, and response to interferon therapy in chronic hepatitis C.
    Pirisi M; Fabris C; Soardo G; Bartoli E
    J Hepatol; 1997 Oct; 27(4):768-9. PubMed ID: 9365057
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.